Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference.

Slides:



Advertisements
Similar presentations
Regulation of amounts of various constituents in cigarette smoke.
Advertisements

 2007 Johns Hopkins Bloomberg School of Public Health Section B Non-Combusting Products and Oral Products.
New Tobacco Products: Harm Reduction or Harm Induction? Herbert H. Severson Senior Research Scientist Oregon Research Institute Eugene, Oregon.
An Invitation to Health Chapter 12 Tobacco Use, Misuse, and Abuse
Reducing the toll of smoking-related disease and death: The case for tobacco harm reduction The rationale for establishing low-toxicity smokeless nicotine.
Tobacco & Cancer. Tobacco Use And Cancer Tobacco use, the most preventable cause of death in our society, accounts for at least 30% of all cancer deaths.
The Evaluation of Canada’s Health Warning Messages: 18 Month Follow-Up Murrray Kaiserman 1, Eva M. Makomaski Illing 1, Donna Dasko 2 1 Tobacco Control.
Information on tobacco packages could encourage and help tobacco users to stop using tobacco or find least possible harmful ways of use for those unable.
Chapter 12 Tobacco. Tobacco Use: Scope of the Problem  Cigarette smoking is the major, most pre- ventable cause of disease and premature death in the.
Who tries how? Quit attempts among Swedish smokers Lars M. Ramström Institute for tobacco studies Stockholm, Sweden 6th Annual Conference of the SRNT Europe.
Prevention strategies
James M. Eddy Texas A&M University The Health Effects of Smoking.
Chapter 14 Tobacco Lesson 1 Facts About Tobacco. Building Vocabulary nicotine An addictive, or habit-forming, drug found in tobacco addictive Capable.
Kenneth E. Warner University of Michigan University of Iowa November 15, 2002 Technology, Policy, and the Future of Nicotine Addiction.
Current challenges in tobacco prevention – do new products pose threats or opportunities? Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden.
Evidence-based/Best Practices Tobacco Control Hadii Mamudu, PhD, MPA COPH-China Institute November 17, 2011.
TOBACCO. Tobacco & Youth  “Each day in the U.S., approximately 4,000 adolescents aged try their first cigarette.”  (CDC, 2008)  Approximately.
10 facts on gender and tobacco World Health Organization.
Ryan Liptak, Ryan Merk, Mary Frances Meier Microeconomics.
Snus as a Substitution for Smoking: The Swedish Experience Lars M. Ramström Institute for tobacco studies Stockholm, Sweden.
Tobacco Prevention. What Kills the Most Americans Every Year? Rank them in order from 1-10 AIDS Suicide Alcohol Fires Secondhand Smoke Heroin Tobacco.
Quitting Cigarettes Completely or Switching to Smokeless Tobacco: Do U.S. Data Replicate the Swedish Results? Shu-Hong Zhu University of California, San.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
Department of Medicine. The Harm Reduction Debate Current context of the debate - Snus enthusiasts vs. pessimists Switching from cigarettes to snus alone.
The impact of the EU accession on Croatia Public health policies on tobacco Marta Čivljak, MD, PHD Research Fellow Department of Medical Sociology and.
Characteristics of new tobacco products emerging on the tobacco market: implications for tobacco control policies Lars M. Ramström Institute for Tobacco.
Public Health & Hospital Health Care System Rural Cessation Collaboration to Improve Health.
It’s time to Stop Big Tobacco … … and we need your help.
Smoking cessation aided by low-toxicity smokeless tobacco can save many lives Lars M. Ramström Institute for Tobacco Studies Täby, Sweden UKNSCC 2014 Thursday.
Health Hazards when Smoking
Unit B1a 3.4 Smoking and Health Year 4N 29th November.
Number of deaths (’000s) in 1998 attributable to tobacco use WHO Region Males Females World Health Report 1999 All member states3, Africa 112.
FORMS of TOBACCO. Cigarettes Smokeless tobacco (chewing tobacco, oral snuff) Pipes Cigars Clove cigarettes Bidis Hookah (waterpipe smoking) Image courtesy.
Changes in Patterns of Substance Use ─ Tobacco Lars Ramström Institute for Tobacco Studies Stockholm, Sweden 49th International ICAA Conference on Dependencies.
 2007 Johns Hopkins Bloomberg School of Public Health Section B Tracking Tobacco-Related Death and Disease.
Lars M. Ramström PhD Director, Institute for Tobacco Studies Stockholm, Sweden The Swedish experience the role.
The Role of Harm Reduction in Tobacco control – An Update of Pros and Cons Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 53rd International.
The Heart and Stroke Foundation South Africa Presented by: Zulfa Abrahams (Dietician)
Living Tobacco-Free It really is possible!. Agenda Statistics and mortality risks Health risks Benefits of quitting Ways to quit.
The e-cigarette: opportunity or threat? SSA Annual Symposium 2015 Deborah Arnott Chief Executive Action on Smoking and Health.
Policies for helping smokers who cannot quit: a prerequisite for maximum prevention of tobacco induced diseases Lars M. Ramström Institute for Tobacco.
TOBACCO & YOUTH. Prevalence  “Each day approximately 3,450 young people between 12 and 17 y/o smoke their first cigarette.”  Appox. 850 of them will.
Key prevalence data, Sweden (Source: ITS/FSI study 2001/2002) MALES FEMALES (n=3205) (n=3507) Daily Daily Daily Daily smoking snus use smoking snus use.
Potential Reduced Exposure Products for Tobacco Users: What Do We Need to Know, What Do We Know, and How do We Get There From Here? Thomas Eissenberg,
Trends in electronic cigarette use in England Robert West Emma Beard Jamie Brown University College London
Smoking in England Robert West Jamie Brown University College London 1.
True of false?  The nicotine in cigarettes causes cancer.  False – nicotine is the addictive drug in cigarettes.  Over 1,000 people die each day from.
1 of of 23 What if… An industry markets a product as "safe", but it’s the leading cause of preventable death in the United States?
Tobacco. Nicotine is a stimulant drug found in tobacco products, including cigarettes, clove cigarettes, cigars, chewing tobacco, pipe tobacco, and snuff.
Tobacco Smoking Smokless tobacco. Smoking Why teens start smoking
Strategies for regulation of cigarette emissions The WHO product regulatory approach Nigel Gray David Burns For TobReg Working Group 1 in Conjunction with.
Find out more online: Healthy Lives, Healthy People: A Tobacco Control Plan for England Department of Health, March 2011 Julia.
1 Tobacco smoking: where are we now and what can be done to reduce prevalence? Robert West University College London Cardiff, April 2008.
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
Potential Reduced Exposure Products (PREPs) for Tobacco Users: What Are They and What Do They Do ? Thomas Eissenberg, Ph.D. Department of Psychology and.
Regulation of: - amounts of various constituents in cigarette smoke - information on packages regarding smoke constituents - smokefree tobacco products.
Trends in electronic cigarette use in England
The smoking epidemic and lung cancer in the EU
Drug Trends in Sweden 2017 Figures 1–
Concepts of Fitness & Wellness 8e
Griffith Health Institute
Tobacco & youth.
Trends in electronic cigarette use in England
Trends in electronic cigarette use in England
a specific MRTP ─ Snus ─ a low-toxicity oral tobacco product.
Trends in electronic cigarette use in England
Tobacco.
Tobacco.
Presentation transcript:

Cutting tobacco’s death toll − an overview of different options Lars M. Ramström Institute for Tobacco Studies Stockholm, Sweden 5th Annual Conference of ISPTID, Hong Kong, 24th – 26th November 2006

OVERALL GOAL Reducing tobacco-related death and disease Major strategies: with regard to ”passive smoking” ● Smokefree environment programs with regard to active tobacco use ● Decreased initiation of tobacco use ● Increased cessation of tobacco use ● Minimized exposure to tobacco toxins

Possibilities and limitations of the strategies ● Decreased initiation ● Theoretically ideal, but success rates are modest and payoff in reduction of death and disease comes late. ● Increased cessation ● Payoff in reduction of death and disease comes quite soon, but many users are unable or unwilling to quit. ● Minimized exposure ● Possible means of additional to tobacco toxins reduction of tobacco-related (”Risk reduction”) death and disease.

Major toxins in cigarette smoke ●Nicotine ●Producing dependence but only minor disease risks. ● Carbon monoxide ● Major contributor to CVD. ●Irritant and ● Major contributors to oxidizing gases CVD and lung diseases. ●”Tar” ●Aggregate of carcinogens and other disease producing substances.

Intake of nicotine (summary) An individual SMOKER’S intake of nicotine is NOT determined by the cigarette (so as is the machine yield of nicotine). A SMOKER’S Intake of nicotine is determined by his personal need for nicotine. He adjusts the way he smokes each type of cigarette so that it gives him the amount of nicotine he needs, irrespective of the machine yield from the cigarette in question.

Intake of ”tar”, Example 1: A smoker who needs 1.3 mg nicotine per cigarette (typical average) smokes a cigarette with machine yields of 1.0 mg nicotine and 9 mg tar. Since 1.0 mg nicotine is accompanied by 9 mg tar, 1.3 mg nicotine (intake by this smoker) will be accompanied by 1.3  9 mg = 11.7 mg tar, so, the smoker’s intake of tar is around 12 mg.

Intake of ”tar”, Example 2: A smoker who needs 1.3 mg nicotine per cigarette, smokes Bond Street International (”high tar” brand), and Camel Lights (”low tar” brand). M a c h i n e y i e l d s: T a r/N i c o t i n e r a t i o s BSI:13 mg tar,1.4 mg nicotine,(13/1.4 ≈ 9 mg tar/mg nicotine) CL : 8 mg tar,0.6 mg nicotine,(8/0.6 ≈ 13 mg tar/mg nicotine) Intake of ”tar” from Bond St Intnl: 1.3  9 ≈ 11 mg. Intake of ”tar” from Camel Lights: 1.3  13 ≈ 17 mg.

Comparing brands for toxicity Nicotine - No major differences according to brands (since intake is mainly regulated by the smoker). Other substances - Intake can differ between brands according to the brand-related ratio to nicotine for the substance. - The way the cigarette is smoked does not very much influence the ratios to nicotine.They can therefore serve as approximate comparative indicators of brand-specific toxicity.

Can switching from one to another type of cigarette result in any substantial risk reduction? NO, since brand differences are small. Smokers’ intake of different substances is unrelated to the machine yield figures that are currently prescribed as package labelling in some countries. Such labelling practices are misleading and should therefore be avoided when implementing the FCTC. Labelling rules should rather prescribe information on the true conditions that determine smokers’ intake.

Possible model for meaningful and truthful ”consumer information” on cigarette packages: Your intake of nicotine from one cigarette: 0.5 – 2.5 mg, depending (mainly) on HOW you smoke. One mg of nicotine from this cigarette is accompanied by: Tar: 7-9 mg Carbon monoxide: 6-8 mg Benzene: mg Hydrogen Cyanide: mg Formaldehyde: mg

Can switching from burned to unburned tobacco result in any substantial risk reduction? Probably: YES, because the major harmful toxins in cigarette smoke are formed during the combustion and consequently absent in smokeless tobacco products. Still, some smokeless tobacco products are very harmful, but there is a very wide variation between products at the lower and the upper end of the scale.

Excerpt from: Gray N, Henningfield J. Lancet Sep 9;368(9539):

How hazardous is Sweden’s smokeless tobacco, ”snus” ?

Mean nitrosamine content of moist snuff products from various sources based on dry weight

Does primary snus use make young people more or less likely to start smoking???

ALLMENALLMEN PDSNU Primary Daily SNus Users, 16 % of total, (started daily snus use without previous daily smoking) NON-PDNSU SNUS AND SMOKING, SWEDISH MEN AGES % of PDSNU initiated daily smoking becoming “Secondary Daily SMOkers”, SDSMO 47 % of NON-PDSNU initiated daily smoking becoming “Primary Daily SMOkers”, PDSMO INITIATION OF SMOKING Derived from: Ramström L M, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control 2006: 15:

CHANGES OF INITATION PATTERNS Swedish men born in: RATE OF INITIATION of Primary daily snus use 8 %16 %30 %29 % Primary daily smoking56 %45 %26 %20 % SUM64 %45 %26 %20%

Does snus use make smokers more or less likely to stop smoking ???

ALLMENALLMEN PDSNU Primary Daily SNus Users, 16 % of total, (started daily snus use without previous daily smoking) NON-PDNSU ALLPDSMOALLPDSMO SDSNU Secondary Daily SNus Users, i.e. PDSMO who initiated daily snus use NON-SDSNU SNUS AND SMOKING, SWEDISH MEN AGES % of PDSNU initiated daily smoking becoming “Secondary Daily SMOkers”, SDSMO 47 % of NON-PDSNU initiated daily smoking becoming “Primary Daily SMOkers”, PDSMO 77 % of SDSNU quit smoking completely 52 % of NON-SDSNU quit smoking completely INITIATION CESSATION OF SMOKING OF SMOKING 62 % of SDSMO quit smoking completely SDSMO (These smokers have a history of daily snus use) Derived from: Ramström L M, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tobacco Control 2006: 15: (Prevalence of remaining daily smokers from this category = 1 %) (Prevalence of remaining daily smokers from this category = 13 %) ( Prevalence of remaining daily smokers from this category = 1 %)

QUIT RATE (Proportion of ”Ever daily smokers” having quit completely) All men 59% All women 49% Men WITHOUT a history of daily snus use 51% Women WITHOUT a history of daily snus use 48% Men WITH a history of daily snus use 72% Women WITH a history of daily snus use 71%

Risk reduction by products like snus: some policy considerations (1) Snus use entails nicotine dependence and some health risks, but risk levels are closer to those of no-tobacco-use than to those of cigarette smoking. Primary snus use is associated with reduced likelyhood for onset of smoking. Increase of initiation of snus use is associated with an even greater decrease of initiation of smoking. Secondary snus use is associated with increased likelyhood of stopping smoking. When used as smoking cessation aid, snus is more effective than nicotine gum or patch. Switching from cigarettes to snus may be a first step towards no-tobacco-use. In Sweden snus appears to be a contributing factor behind the low level of tobacco-related mortality.

Risk reduction by products like snus: some policy considerations (2) Regulations are needed to safeguard product quality. Strict legislation is needed to prevent sales to minors and restrain manufacturers from using misleading claims or other undue marketing practices. Labelling of packages should give consumer information regarding product content and characteristics including additives. Public education campaigns should point out actual risks while avoiding the kind of scaremongering that has sometimes been seen in the past. It should be kept in mind that experience from Sweden may not be immediately applicable in other countires.